The FDA’s outside panel of vaccine experts largely agreed for the need to tailor future COVID-19 vaccines during a virtual meeting April 6, though the exact path and timeline to do so is still unclear, according to NPR.
Read the full post on Becker's Hospital Review - Healthcare News
